Bioactivity | Warfarin (WARF-42; Athrombine-K) is a potent anticoagulant agent and a vitamin K1 recycling antagonist to deplete active vitamin K1. Warfarin decreases blood coagulation and prevents blood clot formation by inhibiting vitamin K epoxide reductase[1][2]. | ||||||||||||
Target | IC50: vitamin K1 recycling | ||||||||||||
Name | Warfarin | ||||||||||||
CAS | 81-81-2 | ||||||||||||
Formula | C19H16O4 | ||||||||||||
Molar Mass | 308.33 | ||||||||||||
Appearance | Solid | ||||||||||||
Transport | Room temperature in continental US; may vary elsewhere. | ||||||||||||
Storage |
|
||||||||||||
Reference | [1]. Ansell, J., et al., Pharmacology and management of the vitamin K antagonists: American College of Chest Physicians Evidence-Based Clinical Practice Guidelines (8th Edition). Chest, 2008. 133(6 Suppl): p. 160S-198S. [2]. http://en.wikipedia.org/wiki/Warfarin |